By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Arctic Bioscience AS (ABS.OL)

OSL Currency in NOK
kr 3.74
-kr 0.01
-0.27%
Last Update: 7 Jul 2025, 12:20
kr 100.45M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
kr 1.65 - kr 16.80
52 Week Range

ABS.OL Stock Price Chart

Explore Arctic Bioscience AS interactive price chart. Choose custom timeframes to analyze ABS.OL price movements and trends.

There is nothing to show.

ABS.OL Company Profile

Discover essential business fundamentals and corporate details for Arctic Bioscience AS (ABS.OL) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

24 Feb 2021

Employees

22.00

CEO

Christer L. Valderhaug

Description

Arctic Bioscience AS, a biotechnology company, develops and commercializes pharmaceutical and nutraceutical products. Its development stage product candidate is HRO350, a novel oral treatment for mild-to-moderate psoriasis. The company sells its nutraceuticals as bulk ingredients to other companies under the ROMEGA brand worldwide. Arctic Bioscience AS was incorporated in 2011 and is based in Ørsta, Norway.

ABS.OL Financial Timeline

Browse a chronological timeline of Arctic Bioscience AS corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 7 May 2025

EPS came in at -kr 0.48, while revenue for the quarter reached kr 13.60M.

Earnings released on 30 Sept 2024

EPS came in at -kr 0.48, while revenue for the quarter reached kr 13.60M.

Earnings released on 29 Aug 2024

EPS came in at -kr 0.47, while revenue for the quarter reached kr 8.60M.

Earnings released on 26 Apr 2024

EPS came in at -kr 0.49, while revenue for the quarter reached kr 7.34M.

Earnings released on 9 Apr 2024

EPS came in at -kr 0.47, while revenue for the quarter reached kr 8.60M.

Earnings released on 30 Dec 2023

EPS came in at -kr 0.45, while revenue for the quarter reached kr 33.75M, beating expectations by +332.69%.

Earnings released on 29 Sept 2023

EPS came in at -kr 0.49, while revenue for the quarter reached kr 7.34M.

Earnings released on 29 Aug 2023

EPS came in at -kr 0.45, while revenue for the quarter reached kr 33.75M, beating expectations by +76.70%.

Earnings released on 9 Feb 2023

Earnings released on 31 Dec 2022

EPS came in at -kr 0.39, while revenue for the quarter reached kr 10.03M.

Earnings released on 25 Aug 2022

Earnings released on 7 Apr 2022

Earnings released on 18 Feb 2022

ABS.OL Stock Performance

Access detailed ABS.OL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
ABS.OL
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
ABS.OL
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More